CJC-1295 No DAC (Mod GRF 1-29)

≥99.0% Purity Verified

MODGRF-5MG-B2026

$42.00per 5mg / vial

A 29-amino acid synthetic tetrasubstituted peptide analogue of growth hormone-releasing hormone (GHRH). Engineered with short-acting pulsatile kinetics to stimulate endogenous GH secretion without prolonged pituitary receptor saturation.

Specification5mg / vial

HPLC Purity≥99.0%

Total mg / vial5 mg

SequenceTyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

AvailabilityIn Stock (100 units)

Quantity

Research Use Only: This product is intended solely for in vitro laboratory research and scientific study. Not for human or veterinary use.

Technical Reference

Product Data Sheet

Identity & Properties

Product NameCJC-1295 No DAC (Mod GRF 1-29)

FormatSingle Compound

Specification5mg / vial

Total mg / vial5 mg

Physical FormLyophilised powder

AppearanceWhite to off-white powder

Storage−20 °C (long-term)

Shelf Life24–36 months (sealed)

SolubilitySoluble in water / acetic acid

Analytical Data

HPLC Purity≥99.0%

Identity MethodMass Spectrometry (MS)

MS ToleranceΔ < 0.05 Da

Testing LabISO 17025-accredited

Batch CodeMODGRF-5MG-B2026

Synthesis MethodSPPS (Solid-Phase)

Lot TraceabilityFull lot-locked

Handling & Safety

Handle in a controlled laboratory environment with appropriate PPE.

Reconstitute only with sterile bacteriostatic water or acetic acid as appropriate.

Aliquot and store at −20 °C. Avoid repeated freeze-thaw cycles.

Not for human, veterinary, or agricultural use under any circumstances.

Dispose of in accordance with local laboratory waste regulations.

Regulatory Notice

This product is an analytical reference material for in-vitro research only. It has not been evaluated by the FDA or any regulatory authority. Purchase and use must comply with all applicable laws in your jurisdiction.